## Abstract Activating the ERK pathway (extracellular signalβregulated kinase pathway) has proven beneficial in several models of Huntington's disease (HD), and drugs that are protective in HD models have recently been found to activate ERK. Thus, the ERK cascade may be a potential target for thera
β¦ LIBER β¦
Targeting Ras/ERK signaling in the striatum: will it help?
β Scribed by Brambilla, R
- Book ID
- 110059606
- Publisher
- Nature Publishing Group
- Year
- 2003
- Tongue
- English
- Weight
- 74 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1359-4184
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A novel target for Huntington's disease:
β
Bodai, LΓ‘szlΓ³ (author);Marsh, J. Lawrence (author)
π
Article
π
2011
π
John Wiley and Sons
π
English
β 300 KB
π 1 views
A novel target for Huntington's disease:
β
Bodai, LΓ‘szlΓ³ (author);Marsh, J. Lawrence (author)
π
Article
π
2011
π
John Wiley and Sons
π
English
β 300 KB
π 1 views
Cell Death Signaling in Cancer Biology a
β
Johnson, Daniel E.
π
Article
π
2012
π
Springer New York
β 1008 KB
miR-520c and miR-373 upregulate MMP9 exp
β
Ping Liu; Michael J. Wilson
π
Article
π
2011
π
John Wiley and Sons
π
English
β 721 KB
## Abstract MicroRNA 520c and 373 (miRβ520c and miRβ373) have been characterized as oncogenes and play critical roles in cancer cell metastasis. However, the relationship between these two microRNAs and matrix metalloproteinases (MMPs), which are important in cancer cell metastasis, remains unknown